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Abstract
Invariant natural killer T (iNKT) cells are innate-like lymphocytes that protect against infection, 
autoimmune disease and cancer. However, little is known about epigenetic regulation of iNKT cell 
development. Here, we show that the H3K27me3 histone demethylase UTX is an essential cell-
intrinsic factor that controls an iNKT lineage-specific gene expression program and epigenetic 
landscape in a demethylase activity dependent manner. UTX-deficient iNKT cells exhibited 
impaired expression of iNKT signature genes due to a decrease in activation-associated H3K4me3 
and an increase in repressive H3K27me3 marks within the promoters that UTX occupies. We 
identified JunB as a novel regulator of iNKT development and show that target gene expression of 
both JunB and iNKT master transcription factor PLZF was UTX-dependent. We determined iNKT 
super-enhancers and demonstrated that UTX-mediated regulation of super-enhancer accessibility 
was a key mechanism for iNKT lineage commitment. These findings reveal how UTX regulates 
iNKT cell development through multiple epigenetic mechanisms.
Invariant natural killer T (iNKT) cells are a subset of T lymphocytes with a limited T cell 
antigen receptor (TCR) repertoire that recognizes lipid antigens presented by CD1d 
molecules on the surface of antigen-presenting cells1,2. The prototypical lipid antigen is the 
glycosphingolipid α-galactosylceramide (α-GalCer) derived from a marine sponge3, which 
can be loaded onto CD1d tetramers for the detection of iNKT cells through binding to their 
invariant TCR. Following antigen recognition, iNKT cells respond rapidly in an innate-like 
fashion and secrete inflammatory cytokines, including interferon-γ (IFN-γ) and 
interleukin-4 (IL-4), in copious amounts1,2. This early response influences the outcome of 
downstream immune reactions and endows iNKT cells with regulatory properties. Due to the 
diversity of their effector functions, iNKT cells are involved in many pathological processes. 
Accordingly, they are important in host defense against infections, prevent autoimmune 
disorders, and protect against cancer1,4.
Deciphering molecular mechanisms that control iNKT lineage specification is essential for 
developing potential therapeutic applications that target iNKT cells. Commitment to the 
iNKT lineage involves positive selection of iNKT cell precursors by CD4+CD8+ double-
positive (DP) thymocytes that express CD1d-glycolipid complexes5. After positive selection, 
TCR signaling activates the calcineurin-NFAT pathway that induces expression of 
transcription factor Egr2 (ref.6). Following its induction, Egr2 activates the iNKT master 
regulator PLZF (encoded by Zbtb16) and the IL-2–IL-15 receptor common β subunit 
(CD122, encoded by Il2rb) that lead to subsequent steps of iNKT cell development, 
comprising cytokine expression and proliferation in response to the IL-15–CD122 axis7–10. 
T-bet (encoded by Tbx21) is a key transcription factor that regulates iNKT cell 
differentiation and acquisition of NK cell traits during terminal maturation. After egress 
from the thymus, iNKT cells mostly reside in the liver and spleen to perform effector 
functions11. Although recent reports contribute to an understanding how key transcription 
factors establish iNKT cell identity in a stepwise process12,13, it is unclear how a multitude 
of transcription factors is orchestrated within an epigenetic framework that controls lineage-
specific gene expression in iNKT cells.
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During development, cell fate determination relies on the activation of cell type-restricted 
transcription factors that act at promoters and enhancers of genes. This requires epigenetic 
programming to ensure the establishment of a proper chromatin organization. Stretch-
enhancer elements (often called super-enhancers) play a critical role in the control of cell 
identity14,15. Dynamic regulation of the histone methylation state at promoters or enhancers 
by histone-modifying enzymes is a key epigenetic mechanism that impacts lineage-specific 
gene expression16–18. The polycomb repressive complex 2 (PRC2) catalyzes the 
trimethylation of histone H3 on lysine 27 (H3K27) that is associated with poised or 
repressed states of promoters and enhancers17,19,20. By contrast, demethylation of 
H3K27me3 by the histone demethylases UTX (ubiquitously transcribed tetratricopeptide 
repeat, X chromosome, encoded by Kdm6a) and JMJD3 (Jumonji C domain-containing 
protein 3, encoded by Kdm6b) correlates with active chromatin states that facilitate gene 
expression21–25. UTX and JMJD3 serve important roles in early development21–23,26, 
epigenetic reprogramming27, cellular differentiation24,28–30, and cancer31,32. The role of 
UTX in different T lymphocyte subsets has been addressed recently33–35, however, the 
underlying mechanisms remained to be elucidated.
In this study, we assessed the epigenetic mechanisms through which UTX controls the 
development of iNKT cells. UTX deficiency resulted in downregulation of iNKT signature 
genes, including Tbx21, Il2rb, and Klrd1, and blocked iNKT cell development. We 
demonstrated that H3K27me3 abundance was increased and H3K4me3 abundance was 
decreased around the promoters of downregulated signature genes in UTX-deficient iNKT 
cells. We found that UTX partners with the iNKT master regulator PLZF, and UTX-deficient 
iNKT cells failed to activate PLZF target genes and harbored increased H3K27me3 around 
their gene promoters. Moreover, we identified a novel role for the AP-1 transcription factor 
JunB in iNKT cell generation. By uncovering the super-enhancer landscape of iNKT cells, 
we demonstrated that UTX is required for the accessibility of the super-enhancers that 
mediate iNKT lineage specification. Thus, we found that UTX engages multiple gene 
regulatory mechanisms to facilitate lineage-specific gene expression and development of 
iNKT cells.
RESULTS
UTX is required for iNKT cell development
Initially, we determined requirements for UTX (Kdm6a) and JMJD3 (Kdm6b) broadly in the 
hematopoietic system. For this purpose, we generated conditional UTX-deficient (UTX-KO) 
and JMJD3-deficient (JMJD3-KO) mice prior to interbreeding with a Vav-Cre allele for gene 
inactivation in the adult hematopoietic system (Supplementary Fig. 1a–e). We observed that 
iNKT cell numbers were strikingly decreased in thymus, spleen, and liver of UTX-KO or 
JMJD3-KO mice as compared to wild-type controls, with a more pronounced effect in UTX 
deficiency (Fig. 1a). UTX and JMJD3 double-knockout (DKO) animals had a similar 
phenotype to UTX-KO, suggesting JMJD3 ablation had no additive effects. We confirmed 
the deletion of Utx and Jmjd3 transcripts in blood, DP thymocytes, and iNKT cells of 
knockout animals by qPCR (Supplementary Fig. 1f). Using molecular markers to distinguish 
the stages of iNKT cell development36, analysis of the remaining thymic iNKT cells in 
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UTX- or JMJD3-KO mice revealed a maturation block that prevented iNKT cells from fully 
entering into stage 3 with a relative accumulation in stages 1 and 2 (Fig. 1b–d). These results 
indicate that UTX and JMJD3 play a selective role in iNKT cells during blood cell 
differentiation. Since the iNKT cell phenotype proved to be predominant in UTX deficiency, 
we focused subsequent analyses on UTX.
Next, we assessed the influence of UTX loss on the functional properties of iNKT cells. 
After stimulation with α-GalCer, IFN-γ production was reduced in thymic iNKT cells of 
UTX-deficient mice compared to wild-type, reflecting a lack of fully mature cells 
(Supplementary Fig. 2a). However, synthesis of IL-4 in the thymus and IFN-γ production of 
the few remaining liver iNKT cells in UTX-KO mice was unaltered (Supplementary Fig. 
2a). A recent classification, though not mutually exclusive to the maturation model, 
describes iNKT cell development by the subtypes NKT1, NKT2, and NKT17, based on their 
cytokine profile and specific transcription factors37. We observed a significant reduction of 
T-bet-dependent NKT1 cells in UTX-deficient mice compared to wild-type (Supplementary 
Fig. 2b). To exclude that the impaired development of iNKT cells was a consequence of 
failure in antigen presentation or the rearrangement of the Vα14-Jα18 TCR, we 
demonstrated equivalent CD1d expression and abundance of Vα14-Jα18 transcripts between 
UTX-deficient and wild-type DP thymocytes (Supplementary Fig. 2c,d). Thus, UTX does 
not primarily affect the function, but rather the development of iNKT cells.
UTX controls iNKT lineage-specific gene expression
To elucidate the molecular mechanism by which UTX contributes to iNKT cell 
development, we sorted thymic iNKT cells from UTX-deficient or wild-type mice and 
performed gene expression analysis (Supplementary Fig. 3a). Compared to wild-type, 
downregulated genes in UTX-KO iNKT cells consisted of genes that are induced during 
iNKT cell maturation and included the critical transcription factor T-bet (Tbx21)11, NK cell 
receptor NKG2D (Klrk1), chemokine and cytokine receptors Cxcr3 and CD122 (Il2rb)9, as 
well as cytokine IFN-γ (Ifng), and calcium regulator Calcyclin (S100a6)13 (Fig. 2a). Gene 
set enrichment analysis (GSEA) of downregulated genes in UTX-deficient iNKT cells 
revealed enrichment for genes involved in iNKT cell differentiation as well as signaling 
pathways, including IL-12 and NFAT that have been previously reported to play important 
roles in iNKT cells6,13 (Fig. 2b, Supplementary Fig. 3b). We validated the gene expression 
of a subset of UTX-dependent downregulated signature genes by qPCR and observed 
marked downregulation of Tbx21, S100a6, the NK cell receptors Klrd1 and Klrk1, Cxcr3, 
and Il2rb in UTX-deficient thymic iNKT cells (Fig. 2c). Correspondingly, iNKT cells from 
UTX-KO mice expressed less protein of those gene products (Fig. 2d). By contrast, UTX 
deficiency resulted in upregulation of genes involved in cell cycle, DNA replication, and 
DNA repair pathways (Supplementary Fig. 3c). We confirmed loss of Utx transcripts and 
UTX-dependent downregulation of signature genes in different stages of UTX-KO iNKT 
cells (Supplementary Fig. 3d,e). These findings indicate that iNKT cell development 
requires a UTX-mediated lineage-specific gene expression program.
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UTX regulates the epigenetic landscape of iNKT cells
UTX-mediated H3K27 demethylation and concomitant catalysis of H3K4 trimethylation by 
MLL2 around the promoters correlates with active gene expression23. Therefore, we 
hypothesized that during iNKT cell development, transcriptional activation of iNKT lineage-
specific genes involves UTX-dependent chromatin regulation. To address this hypothesis, we 
examined the epigenetic landscape of iNKT cells from UTX-KO or wild-type thymi by 
genome-wide ChIP-Seq analysis for H3K4me3 and H3K27me3 marks, correlating with 
activation or repression, respectively. We applied model-based analysis of ChIP-Seq 
(MACS2) to identify distinct peaks in each condition. Although genome-wide H3K4me3 
peaks were largely shared between wild-type and UTX-KO iNKT cells (Fig. 3a), genome-
wide H3K27me3 peaks were greatly increased in the absence of UTX (Fig. 3b), consistent 
with the role of UTX in H3K27me3 demethylation. In addition to this accumulation in 
global H3K27me3 content in UTX-KO iNKT cells (9,645, Fig. 3b), we observed that some 
regions exhibited wild-type-specific H3K27me3 peaks (4,250, Fig. 3b). While chromosomal 
distributions of wild-type- and UTX-KO-specific H3K27me3 peaks were similar 
(Supplementary Fig. 4a,b), wild-type-specific H3K27me3 peaks were more abundant in 
distal intergenic regions compared to UTX-KO-specific peaks (33.5% WT vs. 24.7% UTX-
KO, Supplementary Fig. 4c,d). Notably, we detected increased abundance of UTX-KO-
specific H3K27me3 peaks in proximal promoters compared to wild-type-specific peaks 
(10.4% WT vs. 13.4% UTX-KO, Supplementary Fig. 4c,d). Genomic Regions Enrichment 
of Annotations Tool (GREAT) analysis demonstrated that regions with a loss of H3K27me3 
peaks in UTX-KO iNKT cells were enriched for bivalent genes that harbor both H3K27me3 
and H3K4me3 in their promoters, as well as genes that are involved in erythrocyte 
development (Supplementary Fig. 5a). Interestingly, regions that gained H3K27me3 peaks in 
UTX deficiency were enriched for genes that require MLL for their transcription, as well as 
genes induced in memory T cells (Supplementary Fig. 5b).
Since UTX-mediated alterations of histone marks around promoters impact gene expression, 
we interrogated the average histone mark abundance at iNKT cell gene promoters (Fig. 3c–
e). In UTX-KO iNKT cells, we observed a significant accumulation of H3K27me3 around 
the transcription start sites (TSS, indicated as 0 in the graph) and the promoters of 
downregulated genes (Fig. 3d, Supplementary Fig. 5c, P < 1 × 10−5, permutation test). 
Moreover, we observed a marked reduction of H3K4me3 in the downregulated genes of 
UTX-KO iNKT cells (Fig. 3d, P < 1 × 10−5, permutation test). While there was a less 
significant accumulation of H3K27me3 around upregulated gene promoters of UTX-KO 
iNKT cells compared to downregulated genes (Supplementary Fig. 5d, P = 9 × 10−4), there 
was no notable change in H3K4me3 abundance (Fig. 3e, P = 0.16). GREAT analysis of the 
promoter regions of downregulated genes revealed enrichment for genes involved in iNKT 
cell development (Supplementary Fig. 5e), while analysis of upregulated genes 
demonstrated association with cell cycle and DNA repair pathways (Supplementary Fig. 5f). 
These results suggest that UTX controls iNKT development by regulating the chromatin 
landscape around the promoters of downregulated genes that are involved in iNKT cell 
differentiation.
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iNKT signature gene promoters are regulated by UTX
To uncover different patterns of chromatin state and explore promoters that exhibit 
significant UTX-dependent chromatin regulation, we identified clusters based on the 
distribution of H3K4me3 and H3K27me3 around the promoters of downregulated genes 
(Fig. 3f–i, Supplementary Fig. 6a) and upregulated genes (Supplementary Fig. 6b,c). For 
downregulated genes, cluster 1 contained gene promoters with similar abundance of 
H3K4me3 in both wild-type and UTX-KO iNKT cells and a modest increase in H3K27me3 
in the absence of UTX (Fig. 3f). Cluster 2 consists of gene promoters with very low amounts 
of H3K4me3 and comparable abundance of H3K27me3 in both wild-type and UTX-KO 
iNKT cells (Fig. 3g). Interestingly, promoters in cluster 3 (Fig. 3h) and cluster 4 (Fig. 3i) 
had a striking reduction in H3K4me3 content and accumulation of H3K27me3, especially 
around the TSS (P < 1 × 10−5, permutation test), suggesting that these promoters are affected 
by UTX-dependent chromatin regulation. Integrating gene expression data with chromatin 
state revealed that genes most downregulated in expression are grouped within cluster 3, 
highlighting that UTX-mediated removal of H3K27me3 around these promoters is critical 
for activation of transcription (Fig. 3h). We assessed the identity of these promoters in 
cluster 3 and cluster 4 (Supplementary Table 1) that exhibited significant UTX-dependent 
chromatin regulation by GREAT analysis. We found that immune response genes and 
signature genes of iNKT cell differentiation were significantly enriched in cluster 3 (Klr 
family, Cxcr3, S100a6) and cluster 4 (Tbx21) (Supplementary Fig. 6d). Cluster analysis of 
upregulated genes showed that abundance of H3K4me3 and H3K27me3 was largely 
comparable between UTX-KO and wild-type iNKT cells (Supplementary Fig. 6b,c). These 
results underscore that UTX deficiency specifically affects the chromatin state around the 
promoters of a subset of downregulated genes, which constitutes the iNKT cell signature in 
cluster 3 and cluster 4, without a robust effect on the chromatin state of other genes.
UTX binds to iNKT signature gene promoters
To assess specific alterations in H3K4me3 and H3K27me3 content around the UTX-
dependent gene promoters, we generated overlay tracks of ChIP-Seq data from wild-type 
and UTX-KO iNKT cells using Integrative Genomics Viewer (IGV). We found a marked 
reduction in H3K4me3 abundance and an accumulation of H3K27me3 around the promoters 
of signature genes S100a6, Il2rb, Klrd1, Klrk1, Cxcr3, and Tbx21 in UTX-KO iNKT cells 
(Fig. 4a–e). To investigate whether UTX is physically recruited to these promoters, we 
performed UTX ChIP-PCR on sorted wild-type iNKT cells. Compared to the housekeeping 
gene Actin (Actb) which was not regulated by UTX based on gene expression and ChIP-Seq 
data, we detected significant occupancy of UTX at the promoter regions of the representative 
genes Tbx21, Il2rb, S100a6, and Klrd1 (Fig. 4f). These results suggest that UTX directly 
controls the epigenetic landscape around the promoters of iNKT lineage-specific genes to 
facilitate their transcription.
UTX enzyme activity is required for iNKT development
Although the data above strongly implicate a critical role of UTX in regulating iNKT 
lineage-specific gene expression and development, it is important to assess whether UTX 
directly acts within iNKT cells. A peculiarity of iNKT cells is that they originate from and 
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concomitantly are selected by DP thymocytes38. This feature allows the use of mixed bone 
marrow chimeric mice to distinguish whether a gene defect is intrinsic to iNKT cells, or if 
extrinsic antigen presentation and selection by CD1d-expressing DP thymocytes is 
responsible for an observed phenotype. We transferred bone marrow cells from wild-type 
and UTX-deficient mice in a 1:1 ratio into Rag2−/− animals, and subsequently determined 
the contribution of each donor bone marrow to the overall iNKT cell pool in recipient hosts. 
In the thymus, the population of stage 0–1 iNKT cells of UTX-deficient origin predominated 
over wild-type cells, which was due to relative accumulation of immature iNKT cells in 
UTX deficiency (Supplementary Fig. 7a,b). Accordingly, the majority of iNKT cells at stage 
3 were of wild-type origin, indicating again a block of maturation in the absence of UTX 
(Supplementary Fig. 7a, b). In the liver, most iNKT cells were wild-type and few UTX-
deficient cells contributed to the peripheral iNKT cell pool (Supplementary Fig. 7c). 
Conventional T cells displayed a balanced mixed chimerism, highlighting a specific effect of 
UTX in iNKT cells (Supplementary Fig. 7c). Thus, the block in maturation reflects an 
intrinsic defect in iNKT cells imposed by loss of UTX, which cannot be rescued by the 
presence of wild-type DP thymocytes.
Next, we asked whether the downregulated gene expression program and developmental 
block of iNKT cells could be rescued by in vivo reconstitution with UTX, and whether its 
demethylase activity is required. Using lentiviral transduction of bone marrow cells followed 
by transplantation, UTX-deficient bone marrow transduced with an empty virus failed to 
produce a proper population of iNKT cells in the thymus (Fig. 5a). Importantly, UTX-KO 
bone marrow reconstituted with UTX exhibited substantial iNKT cell development, whereas 
reconstitution with an enzyme-dead mutant failed to generate a sizeable iNKT cell 
population (Fig. 5a). Upon analysis of the different maturation stages of iNKT cells, we 
observed that the few UTX-KO iNKT cells that developed from bone marrows transduced 
with empty virus or enzyme-dead mutant UTX could not fully mature to stage 3 (Fig. 5b). In 
sharp contrast, UTX reconstitution facilitated full development of iNKT cells in the thymus 
(Fig. 5b). We found that liver iNKT cells were virtually lacking in the UTX-KO group 
transduced with empty virus. UTX reconstitution rescued this phenotype by engendering a 
sizable liver iNKT cell population, whereas only a very minor iNKT cell fraction developed 
in the presence of enzyme-dead UTX (Fig. 5c,d). We demonstrated that Utx gene expression 
was comparable between full-length and enzyme-mutant UTX reconstituted mice, excluding 
different reconstitution efficiencies (Fig. 5e). In parallel, we analyzed the gene expression of 
iNKT cells from thymi of reconstituted mice. Notably, reconstitution with full-length UTX 
rescued expression of the iNKT cell signature, including Tbx21, Klrd1, and Cxcr3 (Fig. 5e). 
By contrast, enzyme-dead UTX failed to rescue signature gene expression, although an 
enzyme-independent contribution could be observed for Tbx21 (Fig. 5e). Altogether, these 
data demonstrate that the enzymatic demethylase function of UTX is essential for the proper 
generation of iNKT cells by establishing the iNKT gene expression program.
JunB is a novel regulator of iNKT development
To gain further mechanistic insights how UTX regulates gene expression in iNKT cells, we 
performed motif enrichment analysis (using Haystack, please see Methods) and identified 
potential transcription factors that work together with UTX on iNKT signature gene 
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promoters. We found significant enrichment of the target motifs for the AP-1 transcription 
factors JunB and JunD in cluster 3, as well as RAR/RXR in cluster 4, around the promoters 
of genes that showed UTX-dependent chromatin and transcriptional regulation (Fig. 6a). To 
test whether JunB directly regulates UTX-dependent iNKT cell genes, we performed JunB 
ChIP-PCR. JunB bound the promoters of signature genes from cluster 3 that were enriched 
for JunB motifs (Il2rb and Klrd1) (Fig. 6b, Supplementary Table 2). To assess whether UTX 
cooperates with this putative iNKT transcription factor, we performed immunoprecipitation 
using iNKT cell lysates and demonstrated that UTX interacts with JunB (Fig. 6c). Notably, 
UTX was also able to specifically bind the iNKT cell transcription factor PLZF (Fig. 6c). 
Furthermore, JunB expression was preferentially induced in iNKT cells compared to other 
thymocyte subsets, highlighting a potential role of JunB in iNKT cell generation (Fig. 6d). 
To test this hypothesis, we analyzed JunB-deficient (JunB-KO) mice and found that the 
frequencies of conventional CD4+ and CD8+ T cells, as well as DN and DP thymocytes 
were similar in JunB-KO animals compared to wild-type (Fig. 6e). However, the frequency 
of thymic and peripheral iNKT cells was significantly reduced in JunB-KO mice (Fig. 6f,g). 
To assess whether JunB regulates the transcription of UTX-dependent iNKT signature genes 
in cluster 3, we performed qPCR using sorted thymic iNKT cells from WT and JunB-KO 
mice. We found that signature genes Il2rb and Klrd1 (both gene promoters are bound by 
JunB, Fig. 6b) are significantly downregulated in JunB-KO iNKT cells (Fig. 6h). Taken 
together, these results show that UTX interacts with transcription factors, such as JunB, to 
establish lineage-specific gene expression in iNKT cells.
UTX-deficient iNKT cells fail to activate PLZF target genes
In light of physical association of UTX with PLZF, we asked whether UTX regulates PLZF-
mediated activation of gene expression in iNKT cells. By utilizing a PLZF ChIP-Seq data set 
that defined PLZF-activated genes in iNKT cells39, we determined that loss of UTX in iNKT 
cells leads to impaired activation of PLZF target gene expression (Fig. 7a). PLZF-activated 
target genes were significantly downregulated in UTX-KO compared to randomly selected 
genes (Fig. 7b). To assess whether this downregulation is accompanied by promoter 
accumulation of H3K27me3 in UTX-KO iNKT cells, we compared average abundance of 
H3K27me3 around PLZF-activated target gene promoters and randomly selected gene 
promoters. We found that H3K27me3 content around the promoters of PLZF-activated 
genes, but not random genes, is significantly increased in UTX-KO iNKT cells (Fig. 7c). 
Overlay tracks for PLZF target genes including Il18r1, Il12rb1 and Eya2 demonstrate a clear 
UTX-dependent accumulation of H3K27me3 and a concomitant reduction in H3K4me3 
around the promoter regions that PLZF occupies (Fig. 7d–f). Accordingly, we confirmed that 
the expression of Il18r1, Il12rb1 and Eya2 was significantly reduced in UTX-KO iNKT cells 
(Fig. 7g). These data indicate that UTX controls the epigenetic landscape and transcription 
of PLZF-activated genes.
UTX facilitates accessibility of iNKT super-enhancers
Because super-enhancers bestow lineage specificity14,15, and iNKT cells are vulnerable to 
loss of UTX, we hypothesized that another mechanism by which UTX controls iNKT 
lineage commitment is through regulation of super-enhancer accessibility. First, we 
uncovered the super-enhancer landscape of iNKT cells by performing genome-wide 
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H3K27ac ChIP-Seq and defined super-enhancers as large enhancer elements with highly 
abundant H3K27ac14,15. We identified 396 super-enhancers that include elements proximal 
to genes encoding known regulators of the iNKT cell lineage, such as Tbx21, Zbtb16, and 
Il2rb, as well as putative novel regulators, including the transcription factor Junb (Fig. 8a,b, 
Supplementary Fig. 8a,b, Supplementary Table 3). To reveal potential pathways that are 
associated with the genes proximal to the super-enhancers identified in iNKT cells, we 
performed GREAT analysis of the super-enhancer elements. We found that the AP-1 
pathway was significantly enriched in our analysis, corroborating JunB as a crucial novel 
regulator of the iNKT cell lineage (Supplementary Fig. 8c).
To determine whether iNKT super-enhancer accessibility is affected in the absence of UTX, 
we performed an assay for transposase-accessible chromatin using sequencing (ATAC-
Seq)40 that captures accessible chromatin regions in sorted wild-type and UTX-KO iNKT 
cells. Amongst 396 super-enhancers we identified, 109 super-enhancers had wild-type-
specific ATAC-Seq peaks and therefore lost accessibility in UTX-KO iNKT cells (Fig. 8c, 
Supplementary Table 4). We found that genes nearby super-enhancers that showed UTX-
dependent accessibility are downregulated in UTX-KO by comparing log2 gene expression 
ratios (WT/KO) of these genes to all genes (P = 0.002) (Fig. 8d).
To interrogate whether this loss in accessibility of super-enhancers and reduced transcription 
of nearby genes is accompanied by accumulation of H3K27me3 in UTX deficiency, we 
compared average H3K27me3 abundance around the defined iNKT super-enhancer regions 
to randomly picked control regions in UTX-KO iNKT cells. We detected significant 
accumulation of H3K27me3 (P = 1.9 × 10−14) around super-enhancer regions in UTX-KO 
(Fig. 8e). Super-enhancer regions in wild-type iNKT cells exhibited less H3K27me3 
abundance compared to randomly picked control regions (P = 5.9 × 10−10), which is 
consistent with the notion that active enhancers are devoid of H3K27me317,41. Control 
regions in wild-type and UTX-KO iNKT cells had similar H3K27me3 levels (P = 0.14) (Fig. 
8e). Notably, super-enhancers that showed UTX-dependent accessibility are nearby 
important iNKT cell regulators, such as Tbx21 (Fig. 8f, Supplementary Fig. 8a), and Il2rb 
(Fig. 8g, Supplementary Fig. 8b). Furthermore, GREAT analysis demonstrated that genes 
involved in lymphocyte differentiation and IL-2 signaling are enriched around these regions 
(Supplementary Fig. 8d). To determine the transcription factors that bind these super-
enhancers, we performed motif analysis and found enrichment of the transcription factors 
RelA and Bhlhe40 (Supplementary Fig. 8e), which were recently shown to cooperate with T-
bet to control iNKT cell functions42. Although a small fraction of super-enhancers (n = 13) 
gained accessibility in UTX-KO iNKT cells (Fig. 8c, Supplementary Table 4), we could not 
detect any gene set enrichment for these regions (Supplementary Fig. 8d). Overall, these 
results suggest that UTX regulates accessibility of super-enhancers that establish iNKT cell 
identity.
DISCUSSION
Discoveries of key transcription factors8,9,11 and gene expression programs13 contribute to 
an understanding of the iNKT cell lineage. In this context, a recent study showed the 
diversity of gene programs in different iNKT cell subsets based on RNA-Seq transcriptomics 
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and the description of enhancer elements43. However, the epigenetic mechanisms that 
govern iNKT cell identity are undefined. Here, we demonstrate a selective, cell-intrinsic, and 
catalytic role of the H3K27me3 demethylase UTX in regulating the epigenetic landscape 
and lineage-specific gene expression of iNKT cells. Our data and a previous study35 reveal a 
requirement for the H3K27me3 demethylases UTX and JMJD3 in iNKT cell development. 
We found that this requirement is due to UTX-dependent regulation of iNKT signature gene 
expression. UTX-deficient iNKT cells exhibited a developmental block and failed to induce 
expression of transcription factors and signaling molecules involved in iNKT cell terminal 
maturation, such as T-bet (Tbx21)11 and CD122 (Il2rb)9,10.
Epigenetic regulation of gene expression by UTX has been studied primarily in the context 
of demethylation of repressive H3K27me3 marks. Moreover, UTX associates with MLL2, 
which catalyzes trimethylation of H3K4 at the promoters in order to facilitate transcription 
of lineage-specifying genes21,23,29. Accordingly, in iNKT cells, UTX-dependent signature 
gene promoters, such as those in Tbx21 and Il2rb, accumulated H3K27me3 and harbored 
reduced H3K4me3 levels in the absence of UTX.
We found that gene promoters that exhibit UTX-dependent chromatin and transcriptional 
regulation are bound by the AP-1 transcription factor JunB. A previous report that JunB is 
part of a gene network preferentially upregulated in iNKT cells compared to NK cells and 
conventional T cells is consistent with our findings13. While indirect evidence through 
overexpression or deficiency of the negative regulator BATF shows that AP-1 activity 
promotes generation of iNKT cells44,45, lack of the Fos family member Fra2 leads to 
increased iNKT cell numbers46. Interestingly, JunB/AP1 directly controls expression of Ifng, 
a hallmark cytokine released by mature iNKT cells47. Our studies using JunB-deficient mice 
reveal a significant reduction of thymic as well as peripheral iNKT cell numbers. Taken 
together, our data indicate that JunB is a novel regulator that influences iNKT cell 
development.
UTX can function both dependent and independent of its demethylase enzyme activity29,48. 
We found that iNKT cell development requires UTX demethylase activity, highlighting a 
critical role for the removal of H3K27me3 marks from iNKT signature gene promoters. 
Interestingly, iNKT cells lacking components of PRC2, which is responsible for H3K27me3 
deposition, exhibit impaired maturation and increased accumulation in the thymus and 
spleen35,49. It is proposed that iNKT cell development involves transition from a poised 
PLZF (Zbtb16) promoter in DP thymocytes, harboring both H3K27me3 and H3K4me3 
marks, to an active state in iNKT cells, characterized by H3K4me3 and devoid of 
H3K27me335. Although we did not observe significant accumulation of H3K27me3 around 
the PLZF (Zbtb16) promoter and a robust decrease in PLZF expression in UTX-deficient 
iNKT cells, we demonstrated that UTX regulates the expression and epigenetic landscape of 
downstream PLZF-activated genes in iNKT cells.
Recent studies identified super-enhancers demarcated by elevated H3K27ac levels as a 
hallmark of key genes associated with cell identity and genetic risk of disease14,15,50. Our 
study defines for the first time the iNKT cell super-enhancer landscape and demonstrates 
that signature genes, including Zbtb16, Tbx21, and Il2rb, exhibit super-enhancer elements. 
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In addition, we uncovered numerous novel regulators of iNKT cell identity, providing an 
invaluable resource for understanding epigenetic control of iNKT lineage specification and 
disease-associated genes in iNKT cells.
UTX interacts with chromatin regulators like SWI/SNF and the MLL complex that can 
impact enhancer activation23,29,48. Since dynamic regulation of H3K27me3 and H3K27ac 
content determines enhancer activity17,41, another mechanism for UTX-mediated gene 
regulation raised by our study involves control of lineage-specific super-enhancer 
accessibility by UTX in iNKT cells. Accessibility of super-enhancers nearby downregulated 
signature genes, such as Tbx21 and Il2rb, was lost in UTX-deficient iNKT cells. This 
finding suggests that proper maturation of iNKT cells requires a dual mechanism that 
involves UTX-mediated regulation of the epigenetic landscape around both promoters and 
enhancers of signature genes. Taken together, our data offer a new perspective on 
transcriptional control of iNKT cell development and delineate multiple mechanisms that 
UTX engages to regulate the lineage-specific gene expression program of iNKT cells.
Methods
Experimental mice
Targeting strategy for generating Utx (Kdm6a)f/f or Jmjd3 (Kdm6b)f/f mice is shown in 
Supplementary Fig. 1. Briefly, Jmjd3f/f embryonic stem cells (ESCs) were generated by 
flanking exons 17 and 19 of the Jmjd3 locus with loxP sites. These exons encode the 
catalytic JmjC domain. The sequence-verified targeting vector was linearized and 
electroporated into CJ9 ES cells (129sv background). Homologous recombination was 
assessed by Southern blot analysis by digesting genomic DNA with NheI (5′ probe) or KpnI 
(3′ probe), using specific external probes. Utxf/f ESCs were obtained from EUCOMM. 
After sequence and genotype verification, karyotypically normal ESC clones were injected 
into blastocysts to generate chimera. Mice were backcrossed for at least 10 generations to 
C57BL/6 background. Additionally, UTX- and JMJD3-deficient animals were crossed to 
generate doubly deficient mice. Wild-type control mice were derived from littermates. Vav-
Cre, CD45.1-congenic, and Rag2−/− mice were purchased from The Jackson Laboratory. 
JunB-KO (Junbfl/flMORE-Cre) mice were generated as previously described51. Sex- and 
age-matched animals between 8 and 12 weeks of age were used for experiments. To estimate 
proper number of animals, preliminary experiments were performed. Mice were allocated at 
random to experimental groups. Mouse studies were performed in a non-blinded fashion. 
The Institutional Animal Care and Use Committee (IACUC) of Boston Children’s Hospital 
approved all animal experiments.
Reagents
Phorbol myristate acetate (PMA), ionomycin, fetal bovine serum (FBS), and phosphate-
buffered saline (PBS) were purchased from Sigma. Percoll was obtained from GE 
Healthcare Life Sciences. Viability Dyes (eFluor-780 and eFluor-450) were purchased from 
eBioscience. RPMI media 1640 and Propidium Iodide (PI) were purchased from Life 
Technologies. α-Galactosylceramide (PBS57, α-GalCer) was obtained from Enzo Life 
Sciences. Brefeldin A was acquired from BioLegend.
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Antibodies
For flow cytometry, cells were stained with following antibodies: anti-CD3ε (145-2C11), 
anti-CD8 (53-6.7), anti-CD4 (GK1.5), anti-CD24 (M1/69), anti-CD45.1 (A20), anti-CD45.2 
(104), anti-B220 (RA3-6B2), anti-NKG2D (CX5), anti-IL-2Rβ (TM-β1), anti-CD94 (18d3), 
anti-IFN-γ (XMG1.2), anti-IL-4 (11B11), and anti-T-bet (4B10) were purchased from 
BioLegend. Anti-NK1.1 (PK136), anti-TCRβ (H57-597), anti-CD44 (IM7), anti-IgG1 
(A85-1), anti-CD1d (1B1), and anti-CD90.2 (53-2.1) were obtained from BD Biosciences. 
Anti-IL-17 (ebio17B7) and anti-Rorγt (AFKJS-9) were purchased from eBioscience. Anti-
PLZF (D-9) was obtained from Santa Cruz Biotechnology. Anti-CXCR3 (220803) was 
purchased from R&D Systems. Anti-S100a6 (EPNCIR121) was obtained from Abcam. 
Anti-CD16/CD32 (2.4G2) was acquired from Bio-Xcell (Malaysia).
Flow Cytometry
Cells were stained with antibodies against surface makers in flow cytometry buffer (PBS 
supplemented with 0.5% bovine serum albumin) on ice for 30 min. Subsequently, cells were 
washed and analyzed using a FACSCanto™ II flow cytometer (BD Biosciences). Propidium 
iodide was added just before flow cytometry analysis to exclude dead cells.
Tetramer analysis
For staining of iNKT cells, Alexa647- or Phycoerythrin (PE)-conjugated α-GalCer-loaded 
CD1d tetramers (shortly called CD1d tetramer) were obtained from the Tetramer Core 
Facility of the NIH. For blocking non-specific binding of immunoglobulin to Fc receptors, 
cells were incubated with anti-CD16/CD32 in flow cytometry buffer for 10 min on ice. After 
incubation, cells were stained with fluorescently conjugated CD1d tetramer and viability dye 
for 40 min on ice. To perform molecular studies, CD1d tetramer-positive cells were sorted 
using FACSARIA III (BD Biosciences).
Intracellular staining for cytokines and transcription factors
To stain cytokines intracellularly, cells were fixed and permeabilized with BD Cytofix/
Cytoperm followed by staining with fluorescently labeled antibodies against IFN-γ, IL-4, or 
IL-17 in Perm wash buffer (BD Biosciences). To analyze expression of transcription factors 
in iNKT cells, thymocytes were stained with fluorescently conjugated CD1d tetramer, 
followed by fixation/permeabilization using the Foxp3/transcription factor staining buffer set 
(eBioscience). Subsequently, cells were incubated with purified anti-PLZF, followed by 
staining with fluorescently labeled anti-mouse IgG1. Thereafter, cells were stained with 
antibodies against T-bet and Rorγt.
Isolation of liver lymphocytes
To isolate liver mononuclear cells, livers were perfused with PBS through the portal vein, 
excised, and minced through a metal mesh. Tissue homogenates were collected in 50 ml of 
media (RPMI supplemented with 2.5% FBS) and incubated for 15 min, prior to taking the 
supernatant. Cells were washed twice, suspended in medium containing 33% Percoll, and 
centrifuged at 500 g at 20 °C without break. Thereafter, cell pellets were collected to 
perform further experiments.
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Measurement of immune responses to α-GalCer
To test the function of thymic iNKT cells in vitro, CD8-negative thymocytes were selected 
using anti-CD8 conjugated to magnetic beads and MACS columns (Miltenyi Biotec), 
according to manufacturer’s protocol. Subsequently, cells were stimulated with 50 ng/ml of 
PMA and 5 µg/ml of ionomycin in culture medium (RPMI supplemented with 10% FBS) for 
4 h. Brefeldin A was added for the last 2 h. To measure the in vivo responses to α-GalCer, 
mice were injected with 250 µg of brefeldin A in 200 µl of PBS, followed 30 min later by 
intraperitoneal injection of 2 µg of α-GalCer in 200 µl of PBS. Mice were sacrificed 2 h 
after α-GalCer injection, and livers were excised for preparation of liver mononuclear cell 
isolation and intracellular cytokine staining as described above.
Mixed bone marrow chimeric mice
Bone marrow cells were isolated from the femurs and tibias of wild-type B6.SJL (CD45.1+) 
or UTX-deficient (CD45.2+) mice. T cells were depleted using biotinylated anti-CD90, anti-
biotin conjugated to magnetic beads, and MACS columns. Rag2−/− mice were irradiated 
with a cesium source (600 rad). Then, irradiated mice were injected intravenously with a 1:1 
mixture of bone marrow cells (2 × 106 per mouse) from UTX-deficient or wild-type B6.SJL 
mice. Chimeras were analyzed 10–12 weeks after bone marrow cell injection.
Lentiviral transduction of bone marrow cells and UTX rescue experiment
Bone marrow cells from WT or UTX-KO mice were isolated and cultured with media 
containing IL-6, IL-3, IL-7, and SCF. After 24 h, cells were counted and spin-infected with 
lentivirus containing full-length UTX (pLVX-EF1a-IRES-mCherry-UTX-WT), or 
catalytically inactive UTX (pLVX-EF1a-IRES-mCherry-UTX-ED), and incubated for 3 h at 
37 °C. After 24 h, cells were spin-infected again with the respective lentivirus and incubated 
for 3–4 h at 37 °C. Infected cells were collected and intravenously injected into irradiated 
(600 rad) Rag2−/− recipient mice.
qRT-PCR
Cells were sorted into TRI Reagent (Life Technologies), and total RNA was isolated 
according to the manufacturer's instructions with following modification: the aqueous phase 
containing total RNA was purified using the RNeasy plus kit (Qiagen). RNA was converted 
to cDNA with cDNA synthesis kit (Bio-Rad). qRT-PCR was performed with SYBR green 
master mix (Bio-Rad) on the Bio-Rad iCycler RT-PCR detection system. Actb was used as a 
housekeeping control. To calculate the relative fold change, the 2−ΔΔCT cycle threshold 
method was used. The following primer sequences were used:
Actb, forward, 5′-TCCAGCCTTCCTTCTTGGGTATGGA-3′,
Actb, reverse, 5′-CGCAGCTCAGTAACAGTCCGCC-3′,
Va14, forward, 5′-GTCCTCAGTCCCTGGTTGTC-3′,
Ja18, reverse, 5′-CAAAATGCAGCCTCCCTAAG-3′,
Tbx21, forward, 5′-AGCAAGGACGGCGAATGTT-3′,
Tbx21, reverse, 5′-GGGTGGACATATAAGCGGTTC-3′,
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S100a6, forward, 5′-GCTCACCATTGGCTCCAAGC-3′,
S100a6, reverse, 5′-GGAAGGCGACATACTCCTGG-3′
Klrd1, forward, 5′-TCTAGGATCACTCGGTGGAGA-3′,
Klrd1, reverse, 5′-CACTTGTCCAGGCAAACACAG-3′,
Klrk1, forward, 5′-ACTCAGAGATGAGCAAATGCC-3′,
Klrk1, reverse, 5′-CAGGTTGACTGGTAGTTAGTGC-3′,
Cxcr3, forward, 5′-TACCTTGAGGTTAGTGAACGTCA-3′,
Cxcr3, reverse, 5′-CGCTCTCGTTTTCCCCATAATC-3′,
Il2rb, forward, 5′-TGGAGCCTGTCCCTCTACG-3′,
Il2rb, reverse, 5′-TCCACATGCAAGAGACATTGG-3′,
Junb, forward, 5′ -CGACTACAAACTCCTGAAAC-3′,
Junb, reverse, 5′-CTGTGTCTGATCCCTGAC-3′,
Utx-delq, forward, 5′-GGTCACTTCAACCTCTTATTGG-3′,
Utx-delq, reverse, 5′-CGACATAAAGCACCTCCTGA-3′,
Jmjd3-delq, forward, 5′-
ATCCGAGGAACCAGACAGCACT-3′,
Jmjd3-delq, reverse, 5′-GAGCATGTTGCCTGTGGATG-3′
Il18r1, forward: 5′-ACTTTTGCTGTGGAGACGTTAC-3′
Il18r1, reverse: 5′- CCGGCTTTTCTCTATCAGTGAAT-3′
Il12rb1, forward: 5′- ATGGCTGCTGCGTTGAGAA-3′
Il12rb1, reverse: 5′- AGCACTCATAGTCTGTCTTGGA-3′
Eya2, forward: 5′- ACCGCTGGGCTCTATCAAG-3′
Eya2, reverse: 5′- GGTAGGACGGATAATCCTGGTG-3′
Gene expression microarray
Wild-type or UTX-KO thymic iNKT cells were sorted into TRI Reagent (Life 
Technologies), and total RNA was isolated as described above. RNA was reverse transcribed 
and amplified using Ovation Pico RNA Amplification System V2 (NuGEN), biotin-labeled 
(Encore Biotin Module, NuGEN), and hybridized to Affymetrix mouse 430A 2.0 arrays. 
Affymetrix CEL files were normalized using the Robust Multi-array Average (RMA) 
method52, and batch effects were removed using ComBat53. Differentially expressed genes 
were detected by lmFit function in the limma package54. Gene set enrichment analysis 
(http://www.broadinstitute.org/gsea/index.jsp) was conducted on a pre-ranked list of 
differentially expressed genes in UTX-KO compared to wild-type iNKT cells. Furthermore, 
Genomic Regions Enrichment of Annotations Tool (GREAT; http://bejerano.stanford.edu/
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great/public/html/splash.php) analysis was performed on differentially expressed genes in 
order to identify their functional annotations55.
Genome-wide ChIP-Seq analysis
ChIP-Seq for histone marks H3K4me3 and H3K27me3 was performed as described 
previously56. Briefly, 1 × 105 FACS-sorted thymic iNKT cells were fixed with 1% 
formaldehyde (EMS) for 5 min at 25 °C. Cells were lysed in 120 µl of ChIP buffer (0.5% 
SDS, 50 mM Tris, pH 8, 10 mM EDTA, 1× complete protease inhibitor cocktail, Roche) and 
were sonicated with an E210 Ultrasonicator (Covaris) in microtubes (Covaris) with the 
following sonication conditions: intensity, 5; duty cycle, 10%; 200 cycles per burst for 60 s 
and repeated 6 times. Sonicated chromatin was collected and diluted with four parts of ChIP 
dilution buffer (1.25% Triton X-100, 12.5 mM Tris, pH 8, 187.5 mM NaCl, 1× complete 
protease inhibitor cocktail). Input samples were collected and stored at −20 °C. Dynabeads 
Protein G (Life Technologies) coupled to specific antibodies were used for overnight 
immunoprecipitation using anti-H3K4me3 (ab8580, Abcam), or anti-H3K27me3 (07-449, 
Millipore). Subsequently, samples were washed and the ChIP immune complexes were 
eluted from the beads twice, using elution buffer (1% SDS and 0.1 M NaHCO3) under 
constant agitation for 30 min. Samples were pooled and incubated overnight at 65 °C for 
reversal of the formaldehyde crosslinks. The samples were then treated for 2 h at 37 °C with 
200 µg RNase A (Qiagen) and 40 µg proteinase K (Life Technologies). ChIP DNA 
fragments were purified with a MinElute Reaction Cleanup kit (Qiagen). ChIP DNA was 
prepared for high-throughput Illumina sequencing with a NEBNext ChIP-Seq Library Prep 
Master Mix Set for Illumina kit (New England BioLabs) and NEBNext Multiplex Oligos for 
Illumina (Index Primers 1–12) according to a modified manufacturer's protocol. For each 
ChIP, the ends of DNA fragments were repaired, dA-tailed and ligated to Illumina adaptors 
according to the kit instructions. DNA fragments 150–600 bp in length were then selected 
with Pippin Prep 2% Agarose Gel Cassettes and the Pippin Prep DNA Size Selection System 
(Sage Science). After each step, DNA was purified with a MinElute Reaction Cleanup Kit or 
a QIAquick PCR Purification Kit (Qiagen). The DNA obtained by ChIP was then amplified 
by 15 cycles of PCR with NEBNext Multiplex Oligos. Amplified DNA was purified with 
DNA to Agencourt AMPure XP beads (Beckman Coulter) in a ratio of 1:1. The 'multiplexed' 
DNA libraries were sequenced on the Illumina HiSeq2000. Chip-Seq raw reads were aligned 
using the Bowtie2 aligner57 on the mouse genome assembly mm9 (National Center for 
Biotechnology Information), and peaks were called using MACS258 with the default 
parameter. To compare the average profiles, the different tracks were down-sampled to the 
same number of reads, and duplicate reads were removed using the PICARD tool (http://
broadinstitute.github.io/picard/). To assess the significance of differences between two 
average profiles in a given region, we computed empirically, using 100,000 permutations, 
the distribution of the differences between two profiles using random assignment.
Cluster analysis of H3K27me3 and H3K4me3
Cluster analysis was performed on promoter regions of different sets of genes. The promoter 
region was defined as transcription start site (TSS) −2 kb and TSS +2 kb. The number of 
clusters was determined using a Silhouette metric59, and K-means were performed thereafter 
using the Euclidean distance.
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UTX and JunB ChIP-PCR
ChIP was performed as described with modifications56. Briefly, 2 × 106 FACS-sorted iNKT 
cells were fixed with 1% formaldehyde (EMS) for 5 min at 25 °C. UTX antibody (Bethyl, 
A302-374) and JunB antibody (CST, C37F9) were incubated with beads for 3–5 hours 
before incubating with sonicated chromatin overnight. ChIP DNA was purified and 
quantified by real-time PCR using the iQ SYBR Green Supermix (Bio-Rad). The following 
primer sequences were used:
S100a6 promoter, forward, 5′-
GAAGGTTCAGCACACAAGCC-3′,
S100a6 promoter, reverse, 5′-
CCCAAAGGAGACCAGTGCAA-3′,
Il2rb promoter, forward, 5′-
TAAGATCTCCTCCTACGCCCA-3′,
Il2rb promoter, reverse, 5′-ATGTGTGAGATGTAGCGGGG-3′
Tbx21 promoter, forward, 5′-
TGAAACTTCACTGGAGCGGG-3′,
Tbx21 promoter, reverse, 5′-
TTCATAAAGCCACAGCAAAGGC-3′,
Klrd1 promoter, forward, 5′-
TGCATCTGTGTCCCACCAAC-3′,
Klrd1 promoter, reverse, 5′-
CCAAGGATGGTGCAGAGATGT-3′,
Actb promoter, forward, 5′-
TGCCCCATTCAATGTCTCGG-3′,
Actb promoter, reverse, 5′-CCACACAAATAGGGTCCGGG-3′
Immunoprecipitation and Immunoblot
Cell lysates were incubated with 5 µg anti-UTX antibody (Bethyl), or anti-rabbit IgG control 
antibody (Santa Cruz) overnight at 4 °C followed by 2 h of incubation with Dynabeads 
Protein G for immunoprecipitation. Protein complexes bound to antibody and beads were 
washed 5 times and eluted with Laemmli sample buffer. Samples were resolved by SDS-
PAGE. Protein interaction was analyzed by immunoblotting with anti-PLZF (R&D, 
AF2944), or anti-JunB primary antibodies, and goat anti-rabbit IgG-HRP secondary 
antibodies, followed by visualization using the Western Lightning Plus ECL detection kit 
(PerkinElmer).
Transcription factor (TF) target motif enrichment using Haystack
To identify potential TFs that mediate the observed gene expression changes, we scanned 
gene promoters for enriched TF motifs using the haystack_motifs utility from the Haystack 
Pipeline (https://github.com/lucapinello/Haystack)41. For analysis, we used the default 
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parameters for the mouse genome: the mm9 genome assembly and the JASPAR motif 
database60. Subsequently, to remove potential false positives, we further integrated gene 
expression data in order to assess their specificity and concordance with gene expression 
changes. In particular, we filtered TF motifs based on visual exploration of the expression 
ratios of TFs and their targets between wild-type (WT) and UTX-KO (KO), using the 
haystack_tf_activity_plane utility.
Super-enhancer analysis
In order to call super-enhancers, we used ROSE, a software method previously developed by 
the Young lab (http://younglab.wi.mit.edu/super_enhancer_code.html)14. In particular, we 
first considered as enhancers peaks of H3K27ac obtained by the software MACS2, and then 
called ROSE with default parameters to define the super-enhancers. Using these settings, 
peaks closer than 12.5 kb are stitched together and then ranked based on the H3K27ac 
intensity. To assign super-enhancers to genes, we used again ROSE with default settings.
Genome-wide ATAC-Seq analysis
ATAC-Seq was performed as previously described42. Briefly, WT and UTX-KO thymic 
iNKT cells were sorted by FACS and lysed in lysis buffer containing 10 mM Tris-HCl pH 
7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL CA-360. The transposition reaction was 
carried out for 45 min using the Illumina Nextera DNA preparation kit (FC-121-1030). DNA 
was purified using the Qiagen MinElute PCR purification kit. Subsequently, library 
amplification was performed using Nextera primers and NEBNext high-fidelity PCR master 
mix. qPCR side reaction was done to determine optimum library amplification in order to 
reduce GC and size bias in the library. The amplified library was purified using the Qiagen 
PCR purification kit and sequenced on the Illumina Hi-Seq 2500. Paired reads were aligned 
to the reference genome using Bowtie2 in paired end mode and with the parameter -X2000 
(fragments up to 2kb). ATAC-Seq peaks were called using MACS2 with the following 
parameters: macs2 callpeak --nomodel --shift -100 --extsize 200. Super-enhancers (SEs) 
more accessible in WT were defined as WT SE regions containing unique WT ATAC-Seq 
peaks, while SEs less accessible in WT were defined as WT SE regions containing unique 
KO ATAC-Seq peaks.
Integrative analysis of SE regions, ATAC-Seq, H3K27me3 levels, and gene expression
To study the potential connection between the level of H3K27me3 and chromatin 
accessibility profiled by ATAC-Seq, we used the defined SEs based on the unique ATAC-Seq 
peaks in WT or KO and profiled the average H3K27me3 level (RPM) in those regions. As a 
control set, we used random regions in the genome. To correlate chromatin accessibility in 
SEs with gene expression, we used the average gene expression level of the genes mapped 
with the ROSE pipeline in each group (closest genes and overlapping genes). As control 
sets, we used all the genes and the genes mapped to all the WT SEs in iNKT cells.
Statistical analysis
Data are presented as mean ± standard error or standard deviation. All samples represent 
independent experiments with biological replicates. Sample size was determined based on 
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the results of preliminary experiments. No blinding was applied in this study. Two-tailed 
unpaired t test, Mann-Whitney U test, and one-way ANOVA with post multiple comparisons 
were applied as indicated, and the P-values are shown for each figure. If not otherwise 
indicated the P value was not statistically significant (P > 0.05). All statistical analyses for 
animal studies were calculated using Prism software (GraphPad).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This work was supported by the Howard Hughes Medical Institute (S.H.O.), and by NIH P30DK0492 (S.H.O.) and 
RO1 AI083426 (F.W.). S.B. was supported by the Cancer Research Institute Predoctoral Emphasis Pathway in 
Tumor Immunology. J.H.K. was supported by the National Research Foundation of Korea 
(2012R1A6A3A03040248). L.P. was supported by NHGRI Career Development Award K99HG008399. We thank 
the NIH Tetramer Facility for CD1d-tetramers, the CCCB sequencing facility at DFCI for Illumina HiSeq2000 
sequencing, Microarray core facility at the DFCI Molecular Biology Core Facilities for microarray analysis and the 
DFCI Jimmy Fund FACS core facility for cell sorting.
REFERENCES
1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 2007; 25:297–
336. [PubMed: 17150027] 
2. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI. Recognition of CD1d-restricted antigens by 
natural killer T cells. Nat. Rev. Immunol. 2012; 12:845–857. [PubMed: 23154222] 
3. Kawano T, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by 
glycosylceramides. Science. 1997; 278:1626–1629. [PubMed: 9374463] 
4. Cui J, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 
1997; 278:1623–1626. [PubMed: 9374462] 
5. Bendelac A. Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J. 
Exp. Med. 1995; 182:2091–2096. [PubMed: 7500054] 
6. Lazarevic V, et al. The gene encoding early growth response 2, a target of the transcription factor 
NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol. 2009; 
10:306–313. [PubMed: 19169262] 
7. Kovalovsky D, et al. The BTB-zinc finger transcriptional regulator PLZF controls the development 
of invariant natural killer T cell effector functions. Nat Immunol. 2008; 9:1055–1064. [PubMed: 
18660811] 
8. Savage AK, et al. The transcription factor PLZF directs the effector program of the NKT cell 
lineage. Immunity. 2008; 29:391–403. [PubMed: 18703361] 
9. Seiler MP, et al. Elevated and sustained expression of the transcription factors Egr1 and Egr2 
controls NKT lineage differentiation in response to TCR signaling. Nat Immunol. 2012; 13:264–
271. [PubMed: 22306690] 
10. Matsuda JL, et al. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 2002; 3:966–974. 
[PubMed: 12244311] 
11. Townsend MJ, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i 
NKT cells. Immunity. 2004; 20:477–494. [PubMed: 15084276] 
12. Engel I, Kronenberg M. Transcriptional control of the development and function of Valpha14i 
NKT cells. Curr. Top. Microbiol. Immunol. 2014; 381:51–81. [PubMed: 24839184] 
13. Cohen NR, et al. Shared and distinct transcriptional programs underlie the hybrid nature of iNKT 
cells. Nat Immunol. 2013; 14:90–99. [PubMed: 23202270] 
14. Whyte WA, et al. Master transcription factors and mediator establish super-enhancers at key cell 
identity genes. Cell. 2013; 153:307–319. [PubMed: 23582322] 
Beyaz et al. Page 18
Nat Immunol. Author manuscript; available in PMC 2017 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
15. Hnisz D, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013; 155:934–
947. [PubMed: 24119843] 
16. Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128:693–705. [PubMed: 
17320507] 
17. Rada-Iglesias A, et al. A unique chromatin signature uncovers early developmental enhancers in 
humans. Nature. 2011; 470:279–283. [PubMed: 21160473] 
18. Creyghton MP, et al. Histone H3K27ac separates active from poised enhancers and predicts 
developmental state. Proc. Natl. Acad. Sci. U S A. 2010; 107:21931–21936. [PubMed: 21106759] 
19. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat. 
Rev. Mol. Cell. Biol. 2009; 10:697–708. [PubMed: 19738629] 
20. Bernstein BE, et al. A bivalent chromatin structure marks key developmental genes in embryonic 
stem cells. Cell. 2006; 125:315–326. [PubMed: 16630819] 
21. Agger K, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene 
regulation and development. Nature. 2007; 449:731–734. [PubMed: 17713478] 
22. Lan F, et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature. 
2007; 449:689–694. [PubMed: 17851529] 
23. Lee MG, et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. 
Science. 2007; 318:447–450. [PubMed: 17761849] 
24. De Santa F, et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of 
polycomb-mediated gene silencing. Cell. 2007; 130:1083–1094. [PubMed: 17825402] 
25. Heintzman ND, et al. Histone modifications at human enhancers reflect global cell-type-specific 
gene expression. Nature. 2009; 459:108–112. [PubMed: 19295514] 
26. Welstead GG, et al. X-linked H3K27me3 demethylase Utx is required for embryonic development 
in a sex-specific manner. Proc. Natl. Acad. Sci. U S A. 2012; 109:13004–13009. [PubMed: 
22826230] 
27. Mansour AA, et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic 
reprogramming. Nature. 2012; 488:409–413. [PubMed: 22801502] 
28. Li Q, et al. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell 
differentiation. Nat. Commun. 2014; 5:5780. [PubMed: 25531312] 
29. Lee S, Lee JW, Lee SK. UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to 
activate the cardiac developmental program. Dev. Cell. 2012; 22:25–37. [PubMed: 22192413] 
30. Thieme S, et al. The histone demethylase UTX regulates stem cell migration and hematopoiesis. 
Blood. 2013; 121:2462–2473. [PubMed: 23365460] 
31. Ntziachristos P, et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic 
leukaemia. Nature. 2014; 514:513–517. [PubMed: 25132549] 
32. van Haaften G, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human 
cancer. Nat. Genet. 2009; 41:521–523. [PubMed: 19330029] 
33. Cook KD, et al. T Follicular Helper Cell-Dependent Clearance of a Persistent Virus Infection 
Requires T Cell Expression of the Histone Demethylase UTX. Immunity. 2015; 43:703–714. 
[PubMed: 26431949] 
34. Manna S, et al. Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell 
differentiation. Nat. Commun. 2015; 6:8152. [PubMed: 26328764] 
35. Dobenecker MW, et al. Coupling of T cell receptor specificity to natural killer T cell development 
by bivalent histone H3 methylation. J. Exp. Med. 2015; 212:297–306. [PubMed: 25687282] 
36. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of 
thymic NKT cell development. J. Exp. Med. 2005; 202:485–492. [PubMed: 16087715] 
37. Lee YJ, Holzapfel KL, Zhu J, Jameson SC, Hogquist KA. Steady-state production of IL-4 
modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat 
Immunol. 2013; 14:1146–1154. [PubMed: 24097110] 
38. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes 
that are positively selected by CD1d. Nat. Immunol. 2001; 2:971–978. [PubMed: 11550008] 
39. Mao AP, et al. Multiple layers of transcriptional regulation by PLZF in NKT-cell development. 
Proc. Natl. Acad. Sci. U S A. 2016; 113:7602–7607. [PubMed: 27325774] 
Beyaz et al. Page 19
Nat Immunol. Author manuscript; available in PMC 2017 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
40. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin 
for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and 
nucleosome position. Nat. Methods. 2013; 10:1213–1218. [PubMed: 24097267] 
41. Pinello L, Xu J, Orkin SH, Yuan GC. Analysis of chromatin-state plasticity identifies cell-type-
specific regulators of H3K27me3 patterns. Proc. Natl. Acad. Sci. U S A. 2014; 111:E344–E353. 
[PubMed: 24395799] 
42. Kanda M, et al. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of 
IFN-gamma production in iNKT cells. Proceedings of the National Academy of Sciences of the 
United States of America. 2016
43. Engel I, et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene 
programs. Nat. Immunol. 2016; 17:728–739. [PubMed: 27089380] 
44. Williams KL, et al. BATF transgenic mice reveal a role for activator protein-1 in NKT cell 
development. J. Immunol. 2003; 170:2417–2426. [PubMed: 12594265] 
45. Jordan-Williams KL, Poston S, Taparowsky EJ. BATF regulates the development and function of 
IL-17 producing iNKT cells. BMC Immunol. 2013; 14:16. [PubMed: 23537103] 
46. Lawson VJ, Maurice D, Silk JD, Cerundolo V, Weston K. Aberrant selection and function of 
invariant NKT cells in the absence of AP-1 transcription factor Fra-2. J. Immunol. 2009; 
183:2575–2584. [PubMed: 19620306] 
47. Thomsen MK, et al. JUNB/AP-1 controls IFN-gamma during inflammatory liver disease. J. Clin. 
Invest. 2013; 123:5258–5268. [PubMed: 24200694] 
48. Miller SA, Mohn SE, Weinmann AS. Jmjd3 and UTX play a demethylase-independent role in 
chromatin remodeling to regulate T-box family member-dependent gene expression. Mol. Cell. 
2010; 40:594–605. [PubMed: 21095589] 
49. Pereira RM, et al. Jarid2 is induced by TCR signalling and controls iNKT cell maturation. Nat. 
Commun. 2014; 5:4540. [PubMed: 25105474] 
50. Vahedi G, et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature. 
2015; 520:558–562. [PubMed: 25686607] 
References for Methods
51. Passegue E, Wagner EF, Weissman IL. JunB deficiency leads to a myeloproliferative disorder 
arising from hematopoietic stem cells. Cell. 2004; 119:431–443. [PubMed: 15507213] 
52. Irizarry RA, et al. Exploration, normalization, and summaries of high density oligonucleotide array 
probe level data. Biostatistics. 2003; 4:249–264. [PubMed: 12925520] 
53. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using 
empirical Bayes methods. Biostatistics. 2007; 8:118–127. [PubMed: 16632515] 
54. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in 
microarray experiments. Stat Appl Genet Mol Biol. 2004; 3 Article3. 
55. McLean CY, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat 
Biotechnol. 2010; 28:495–501. [PubMed: 20436461] 
56. Kurachi M, et al. The transcription factor BATF operates as an essential differentiation checkpoint 
in early effector CD8+ T cells. Nat Immunol. 2014; 15:373–383. [PubMed: 24584090] 
57. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9:357–
359. [PubMed: 22388286] 
58. Zhang Y, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9:R137. 
[PubMed: 18798982] 
59. Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. 
Journal of Computational and Applied Mathematics. 1987; 20:53–65.
60. Mathelier A, et al. JASPAR 2014: an extensively expanded and updated open-access database of 
transcription factor binding profiles. Nucleic Acids Res. 2014; 42:D142–D147. [PubMed: 
24194598] 
Beyaz et al. Page 20
Nat Immunol. Author manuscript; available in PMC 2017 June 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
H3K27 demethylases are essential for iNKT cell maturation and development. (a) 
Frequency of iNKT cells in UTX KO (n = 5 mice), JMJD3 KO (n = 3 mice), or UTX/JMJD3 
double-deficient (DKO, n = 5 mice) mice. iNKT cells were detected by staining with anti-
CD3 and α-GalCer-loaded CD1d-tetramers (CD1d-tetramer) using flow cytometry. Right 
panel shows absolute cell numbers of iNKT cells in the different experimental groups. (b–d) 
Thymic iNKT cells from experimental groups (n = 4 per group) as described in (a) were 
analyzed for their maturation stages using flow cytometry. (b) Flow cytometry analysis of 
iNKT cells at stage 0 (CD24+CD1d-tetramer+) and stage 1–3 (CD24−CD1d-tetramer+). 
Percentages of iNKT cells are depicted in the dot plots. (c) Thymic iNKT cells were gated 
on CD24−tetramer+ iNKT cells and additionally analyzed for CD44 and NK1.1 expression. 
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Stage 1: CD44−NK1.1−, stage 2: CD44+NK1.1−, stage 3: CD44+NK1.1+. (d) Absolute cell 
numbers of thymic iNKT cells from the experiment described in (b,c). *P < 0.05; **P < 
0.01; ***P < 0.001 (one-way analysis of variance (ANOVA) and multiple comparisons). 
Each symbol represents an individual mouse; data are mean ± s.e.m from three independent 
experiments (a–d)
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Figure 2. 
UTX is required for lineage-specific expression of signature genes in iNKT cell 
development. (a–c) Gene expression profiles of UTX-deficient (UTX KO) or wild-type 
(WT) thymic iNKT cells. (a) Scatter plot shows up- or downregulated genes in UTX KO 
iNKT cells. RMA; Robust Multi-array Average (normalized fluorescence units of the probes 
on array). Data are from two experiments with five mice (WT) or four mice (KO). (b) Gene 
Set Enrichment Analysis (GSEA) of downregulated genes in UTX KO iNKT cells. ES, 
enriched score; NES, normalized ES; FDR, false discovery rate. (c) Expression of 
downregulated genes in UTX KO iNKT cells were validated by quantitative RT-PCR. 
Relative expression values are depicted normalized to Actin. Data are mean ± s.d. from five 
independent experiments. (d) Flow cytometry analysis of thymic iNKT cells from WT or 
UTX-deficient mice, staining for the gene products of the iNKT cell expression signature. 
Analysis is gated on CD3+CD1d-tetramer+ cells, and histograms depict the fluorescence 
intensity of the proteins indicated. Data are representative of three independent experiments.
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Figure 3. 
UTX regulates the chromatin landscape of iNKT cells. (a,b) Genome-wide distribution of 
H3K4me3 (active) or H3K27me3 (repressive) histone marks on UTX-deficient (KO) or 
wild-type (WT) iNKT cells. Data are from two independent experiments. The Venn 
diagrams depict the numbers of genome-wide peaks of the histone marks H3K4me3 (a), and 
H3K27me3 (b), in WT or KO iNKT cells. (c–e) Chromatin landscape of WT or KO iNKT 
cells around gene promoters. 0 marks transcription start site (TSS). Shown is the average 
abundance of H3K27me3 and H3K4me3 depicted as z-score in reads per million (rpm). 
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Average profiles are grouped including (c) all iNKT cell genes, or (d) downregulated genes 
(H3K4me3: P < 1 × 10−5, H3K27me3: P < 1 × 10−5), or (e) upregulated genes (H3K4me3: P 
= 0.16, H3K27me3: P = 9 × 10−4), with WT in blue and KO in green. (f–i) Integrating gene 
expression with chromatin state. Downregulated genes in KO iNKT cells were further 
subdivided into four clusters (C1–C4) dependent on their histone mark pattern. Gene 
expression is shown as logarithmic fold change (log2FC) in a whisker plot. The box extends 
from the lower to upper quartile values of the data, with a line at the median. The whiskers 
extend from the box 1.5 inter-quartile range on each side. Flier points are data points outside 
the whiskers. Average abundance of H3K27me3 and H3K4me3 around gene promoters in 
the different clusters is depicted as z-score in reads per million (rpm). C1–4 = clusters 1 to 4. 
P-values indicate statistical significance based on permutation test where 100,000 
permutations were used to calculate the distribution of the difference between two average 
profiles.
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Figure 4. 
UTX occupies iNKT signature gene promoters that exhibit UTX-dependent chromatin 
regulation. (a–e) ChIP-Seq overlay tracks of H3K27me3 and H3K4me3 marks for 
representative iNKT cell signature genes from UTX-deficient (KO) or wild-type (WT) iNKT 
cells (Data from Fig. 3). Gene structure and direction of transcription is depicted below the 
tracks. Gene promoters are indicated with an asterisk (*). (f) Assessment of UTX occupancy 
around signature gene promoters by ChIP-PCR. Shown is the relative enrichment of 
promoter sequences of iNKT cell signature genes by UTX ChIP compared to isotype control 
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IgG. Actin (Actb) was used as negative control. *P < 0.05, using unpaired t-test. Data are 
mean ± s.d. from three independent experiments.
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Figure 5. 
Demethylase activity of UTX is required for generation of iNKT cells. Bone marrow cells 
from wild-type (WT) mice transduced with lentivirus containing empty vector (empty), or 
UTX-deficient bone marrow (UTX KO) transduced with empty vector (empty), or full-
length UTX (UTX fl), or enzyme-dead UTX (UTX ed), were transferred to Rag2−/− hosts. 
Twelve weeks later, recipient mice were analyzed for frequency and maturation of iNKT 
cells using flow cytometry. (a) Percentages of thymic iNKT cells are depicted in the bar 
graph. (b) Thymic iNKT cell maturation was assessed by measuring CD44 and NK1.1 
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expression gated on CD1d-tetramer+ cells, and is shown in the bar graph according to stages 
1–3. (c,d) Liver iNKT cells were detected as CD3+CD1d-tetramer+ cells, and their 
percentages are depicted in the dot plots (c) and the bar graph (d). (e) Thymic iNKT cells 
from reconstituted mice were analyzed for UTX and signature gene expression by 
quantitative RT-PCR, and relative expression values were normalized to Actin. *P < 0.05, 
**P < 0.01, ***P < 0.001; NS, not significant, using one-way ANOVA and multiple 
comparisons. Data are mean ± s.e.m from two independent experiments with four mice per 
group.
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Figure 6. 
Transcription factor JunB partners with UTX to regulate iNKT cell signature and 
development. (a) AP-1 transcription factor target motifs are enriched among downregulated 
genes in UTX-deficient iNKT cells. For motif enrichment, the analysis tool Haystack was 
used (P-values; JunB: 0.006, JunD: 0.006, RXR/RAR: 0.005). Depicted are target motif 
sequences and the expression ratios of transcription factors (TF) and their targets between 
wild-type (WT) and UTX KO (KO). (b) JunB ChIP-PCR analysis for UTX-dependent gene 
promoters in thymic iNKT cells. Shown is the relative enrichment of promoter sequences of 
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UTX-dependent iNKT cell signature genes after JunB-ChIP compared to the isotype control 
(IgG). Actin (Actb) was used as a negative control. (c) Molecular interaction between UTX, 
JunB, and PLZF in iNKT cells as assessed by immunoprecipitation (IP) for UTX, compared 
to isotype control (IgG) (10% input). Data are representative of three independent 
experiments. (d) JunB expression in thymic CD4, CD8, double-positive (DP), and iNKT 
cells was analyzed by quantitative RT-PCR. Relative expression values were normalized to 
Actin. (e) Percentages of thymic CD4, CD8, double-negative (DN), and double-positive 
(DP) lymphocytes in WT and JunB KO mice. (f,g) Frequency of thymic and liver iNKT cells 
in WT and JunB KO mice was assessed using flow cytometry and depicted in representative 
dot plots (left panels). (h) Reduced expression levels of UTX-dependent iNKT signature 
genes in JunB KO thymic iNKT cells were analyzed by quantitative RT-PCR. Relative 
expression values were normalized to Actin. *P < 0.05, **P < 0.01; NS, not significant, 
using unpaired t-test. Data are mean ± s.e.m from three independent experiments (b–d) or 
two experiments with four mice per group (e–h).
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Figure 7. 
UTX deficiency impairs activation of PLZF target genes in iNKT cells. (a) Heatmap of 
PLZF-activated genes illustrates reduction in gene expression in UTX KO iNKT cells. (b) 
Gene expression log2 ratios (WT/UTX KO) of PLZF-activated genes compared to random 
genes. (c) Accumulation of H3K27me3 marks around PLZF-activated gene promoters in 
UTX KO iNKT cells. Depicted are average levels of H3K27me3 abundance around PLZF-
activated gene promoters (± 1kb of TSS) compared to randomly picked promoters in WT or 
UTX KO iNKT cells. Data are represented with whisker plots (n = 17 regions per group). 
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The box extends from the lower to upper quartile values of the data, with a line at the 
median. The whiskers extend from the box 1.5 inter-quartile range on each side. Flier points 
are data points outside the whiskers. NS, not significant; *P < 0.05, using Mann-Whitney U 
test (b,c). (d–f) Representative tracks demonstrating loss of H3K4me3 and gain of 
H3K27me3 around the PLZF-activated genes: Il18r1 (d), Il12rb1 (e), Eya2 (f). Gene 
structure and direction of transcription is depicted below the tracks. Gene promoters are 
indicated with an asterisk (*). (g) Reduced expression levels of PLZF-activated genes in 
UTX KO thymic iNKT cells were confirmed by quantitative RT-PCR. Relative expression 
values were normalized to Actin. *P < 0.05, using unpaired t-test. Data are mean ± s.d. from 
three independent experiments.
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Figure 8. 
UTX facilitates super-enhancer accessibility in iNKT cells. (a) Ranking of super-enhancers 
(SE) in iNKT cells. SEs were ranked based on H3K27ac signal intensity using the ROSE 
algorithm. (b) H3K27ac ChIP-Seq tracks of representative iNKT cell SEs are shown. Gene 
bodies are depicted above the tracks, and SEs are marked as black bars. Gene promoters are 
indicated with an asterisk (*). (c) Chromatin accessibility of SEs identified in (a) was 
analyzed using ATAC-Seq. The Venn diagram depicts numbers of accessible WT SEs with 
specific WT−, or KO ATAC-Seq peaks in iNKT cells. Data are from two independent 
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experiments. (d) Expression of genes nearby UTX-dependent SEs is downregulated in KO 
iNKT cells. Gene expression log2 ratios (WT/KO) of all genes (n = 20,628), genes nearby all 
defined iNKT cell SEs (n = 396), or iNKT SEs with WT-specific accessibility (UTX-
dependent, n = 109), or iNKT SEs with KO-specific accessibility (n = 13) are shown. Data is 
represented with a whisker plot. *P = 0.002, using Mann-Whitney U test (e) Accumulation 
of H3K27me3 marks around SE regions in KO iNKT cells. Depicted are average levels of 
H3K27me3 abundance in the vicinity of the defined SE regions in (a) compared to randomly 
picked control regions (C) in WT or KO iNKT cells. n = 396 regions per group. Data are 
represented with a whisker plot. *P = 5.9 × 10−10, **P = 1.9 × 10−14 using Mann-Whitney U 
test. (f,g) Representative tracks demonstrating loss of accessibility and gain of H3K27me3 
around the defined SE regions for T-bet (Tbx21) (f) and Il2rb (g). Depicted are the ChIP-Seq 
tracks of H3K27ac and heat maps of ATAC-Seq, H3K27me3, and H3K4me3 in WT or KO 
iNKT cells around the SEs for Tbx21 and Il2rb.
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